Chinese Herbal Medicine Yiqi Jianpi Prescription combined with S-1 as first-line treatment for 41 aged cases of advanced gastric cancer

YU Gen-hua; YAO Qiang; ZHANG Hai-bing; JI Peng-tian; DENG Jian-liang; GU Xian-cheng

doi:10.16025/j.1674-1307.2018.04.012

您当前的位置：

首页 >

文章列表页 >

Chinese Herbal Medicine Yiqi Jianpi Prescription combined with S-1 as first-line treatment for 41 aged cases of advanced gastric cancer

更新时间：2023-04-10

- Chinese Herbal Medicine Yiqi Jianpi Prescription combined with S-1 as first-line treatment for 41 aged cases of advanced gastric cancer
- Beijing Journal of Traditional Chinese Medicine Vol. 37, Issue 4, Pages: 318-320(2018)
- 作者机构：
  
  1. 浙江省湖州市浙北明州医院(湖州市第一医院国际分院)肿瘤放疗科
  2. 江苏大学附属宜兴医院肿瘤科
  3. 浙江省湖州市中心医院介入放疗科
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2018.04.012
  CLC：
扫描看全文
YU Gen-hua, YAO Qiang, ZHANG Hai-bing, et al. Chinese Herbal Medicine Yiqi Jianpi Prescription combined with S-1 as first-line treatment for 41 aged cases of advanced gastric cancer. [J]. Beijing Journal of Traditional Chinese Medicine 37(4):318-320(2018)
DOI：

YU Gen-hua, YAO Qiang, ZHANG Hai-bing, et al. Chinese Herbal Medicine Yiqi Jianpi Prescription combined with S-1 as first-line treatment for 41 aged cases of advanced gastric cancer. [J]. Beijing Journal of Traditional Chinese Medicine 37(4):318-320(2018) DOI： 10.16025/j.1674-1307.2018.04.012.

摘要

目的观察中药益气健脾方联合替吉奥胶囊一线治疗老年晚期胃癌患者的疗效、生活质量及不良反应。方法回顾分析85例老年晚期胃癌患者,按是否口服中药分为2组,口服替吉奥胶囊对照组,口服替吉奥胶囊联合中药益气健脾方观察组;28 d为1个疗程,治疗4个疗程后评价疗效,观察患者的一般情况、各项血液学指标,并随访患者的1年生存率及总生存时间。结果 4周期治疗后对照组Karnofsky评分（KPS）改善率低于观察组,差异有统计学意义（P<0.05）;对照组Ⅱ度以上中性粒细胞下降率高于观察组,差异有统计学意义（P<0.05）。2组消化道反应比较,差异无统计学意义（P>0.05）;近期缓解率（CR+PR）对照组为50.0%,观察组为58.5%,差异无统计学意义（P>0.05）;对照组1年生存率为61.4%,观察组为75.6%,2组比较差异无统计学意义（P>0.05）;Kaplan-Meier生存曲线提示对照组中位生存时间12.6个月,观察组中位生存时间15.6个月,2组间差异有统计学意义（P<0.05）。结论益气健脾中药方剂联合替吉奥胶囊治疗老年晚期胃癌可改善患者生活质量,降低化疗的不良反应,延长患者生存时间。

Abstract

Objective To observe the clinical efficacy,quality of life and adverse reactions of Chinese herbal medicine Yiqi Jianpi Prescription combined with S-1 treatment for aged cases of advanced gastric cancer. Methods A total of 85 aged cases with advanced gastric cancer were retrospectively analyzed. These cases were divided into two groups. The control group was treated with S-1 taken orally only,and the observation group was given S-1 and Chinese herbal medicine Yiqi Jianpi Prescription orally; 28 days constituted one course. The patient’ s general condition and hematological indexes were observed and the efficacy evaluated after 4 courses of treatment with one year following-up of survival rate and overall survival time. Results After 4 courses of treatment,Karnofsky scores（ KPS） improvement rate of the control group was lower than that of the observation group,and the difference had statistical significance（ P ,<, 0. 05）. TheⅡ ,Ⅳ neutrophil decline rate of the control group was higher than that of the observation group,and the difference had statistical significance（ P ,<, 0. 05）. The difference of digestive tract adverse reactions had no statistical significance between the two groups and the difference had no statistical significance（ P ,>, 0. 05）. The recent remission rate（ CR + PR） of the control group and the observation group were 50. 0% and 58. 5% respectively,and the difference had no statistical significance（ P ,>, 0. 05）. The one year survival rate between the two groups（ 61. 4%,75. 6%） also had no statistical significance（ P ,>, 0. 05）. Kaplan-Meier survival curve demonstrated that median survival time of the control group was 12. 6 month and that of the observation group was 15. 6 months,and the difference was statically significant（ P ,<, 0. 05）. Conclusion Chinese Herbal Medicine Yiqi Jianpi Prescription combined with S-1 taken oral could improve the quality of life,reduce the adverse reactions caused by chemotherapy and prolong the overall survival time in aged patients with advanced gastric cancer.

关键词

老年患者晚期胃癌替吉奥中药生活质量

Keywords

aged patientsadvanced gastric cancerS-1Chinese herbal medicinequality of life

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis of clinical characteristics of Chinese and western medicine inpatients with advanced gastric cancer receiving second-line and follow-up treatment

Multi⁃centered randomized controlled study of Chinese medicine integrated with chemotherapy for stage Ⅳ non⁃small cell lung cancer

Analysis onrationality of control types in randomized controlled trials for Chinese herbal medicine for treating type 2 diabetes mellitus

Improvement offacial skin properties in acne patients with damp-heat type by Qingre Chushih Decoction

Formation and mechanism of compound Chinese herbal medicine Xiaoshui Formula to inhibit malignant pleural effusion in mice

Related Author

No data

Related Institution

Department of Hematology and Oncology， Dongzhimen Hosptial， Beijing University of Chinese Medicine

Department of Integrated Traditional Chinese and Western Medicine， The First Affiliated Hospital of Chongqing Medical University

Department of Oncology，Guang'anmen Hospital，China Academy of Chinese Medical Sciences

Department of Oncology，Zhejiang Hospital of Traditional Chinese Medicine

Department of Oncology，The Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine

⁰